510(k) Report

510(k) · Cleared

Cleared

CueSee Hypoxic

K152553510(k) TraditionalCleared Apr 22, 2016227-day reviewClass I21 CFR 862.1660

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Eurotrol B.V. · JJS Controls For Blood-Gases, (Assayed And Unassayed)

Cleared on Apr 22, 2016 as substantially equivalent to K032453 (Bionostics, Inc., 2003) after a 227-day review. Its family tree reaches back 2 generations to 1991.

Decided
Apr 22, 2016
Review
227 days
Class
Class I
Product code
JJS
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K913133 (1991). No later device cites it as a predicate yet.

  1. Root · 2 generations backK913133 Chality Control Material (Assayed & Unassayed)Bionostics, Inc. · 1991
  2. 1 generation backK032453 Roche Combitrol and Autotrol Plus B Multi Analyte ControlBionostics, Inc. · 2003
  3. This deviceK152553 CueSee HypoxicEurotrol B.V. · 2016
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K913133Chality Control Material (Assayed & Unassayed)Bionostics, Inc.1991—
−1K032453Roche Combitrol and Autotrol Plus B Multi Analyte ControlBionostics, Inc.2003—
0 (this device)K152553CueSee HypoxicEurotrol B.V.2016—
FIG. 1 — Lineage of K152553, 1991–2016Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JJS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K032453Roche Combitrol and Autotrol Plus B Multi Analyte Control
Summary page 4
….1660) 5. Predicate Device Device Name: RNA Medical® Brand QC 823 Range Blood Gas Electrolyte Metabolite Control Manufacturer: Bionostics, Inc., 510(k) number: k032453, Decision Date: 08/28/2003 6. Intended Use CueSee® Hypoxic is a pre-tonometered bovine hemoglobin (Hb) quality control mat…
Bionostics, Inc.2003—

Also cleared against K032453: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 25 years and passes through 2 companies; a new generation was cleared every 12.7 years on median.
  • None of the 2 ancestors has a recall.
  • 3 other devices also cite its predicate K032453.

How does its category compare?

All JJS devices

JJS Controls For Blood-Gases, (Assayed And Unassayed): FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · JJS

1in 2016

2013: 22015: 12016: 1
2007high 2 (2013) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JJS

Too few JJS 510(k)s in any year since 2007 to give a median.

Recalls per year · JJS

No recall names JJS since 2007.

Adverse event reports per year · JJS

1in 2018

2017: 12018: 1
2007high 1 (2017) · low 0 (2007)2025

MAUDE reports naming product code JJS, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20132—00
20140—00
20151—00
20161—00
20170—01
20180—01
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

CueSee® Hypoxic is a pre-tonometered bovine hemoglobin (Hb) quality control material for professional use for

monitoring blood gas analyzers’ performance of Oxygen partial pressure (pO2).

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K152553: CueSee Hypoxic.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K152553

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026